+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn

+ Translate
+ Recently Requested

Intensified insulin therapy improved metabolic control without changes of hypoglycemia in 64 insulin treated patients with non insulin dependent diabetes mellitus



Intensified insulin therapy improved metabolic control without changes of hypoglycemia in 64 insulin treated patients with non insulin dependent diabetes mellitus



Diabetologia 40(SUPPL 1): A339




(PDF emailed within 1 workday: $29.90)

Accession: 031974907

Download citation: RISBibTeXText


Related references

Intensified conventional insulin therapy in patients with type 2 diabetes mellitus. Positive long-term effects of insulin lispro on metabolic control and microalbuminuria. Fortschritte der Medizin. Originalien 118(4): 141-146, 2001

Influence of intensified insulin regimen on quality of life and metabolic control in insulin-dependent diabetes mellitus. Diabetes Research & Clinical Practice. 25(2): 111-115, 1994

Insulin glargine plus oral therapy in patients with type 2 diabetes allows flexible dosing and leads to improved metabolic control with less hypoglycemia versus NPH insulin. Diabetes 52(Supplement 1): A443, 2003

Insulin secretion and the control of non insulin dependent diabetes mellitus treated with a combined therapy of insulin and glibenclamide. Diabetologia Croatica 17(4): 319-324, 1988

Change of the complement level in patients with insulin-dependent diabetes mellitus in the course of intensified insulin therapy. Problemy Endokrinologii 38(2): 12-14, 1992

Glycemic control in insulin-dependent diabetes mellitus. Comparison of outpatient intensified conventional therapy with continuous subcutaneous insulin infusion. American Journal of Medicine 72(4): 673-680, 1982

Frequency of severe hypoglycemia in patients with non-insulin-dependent diabetes mellitus treated with sulfonylureas or insulin. Endocrine Practice 3(5): 281-283, 2004

Improved metabolic control in insulin-dependent diabetes mellitus with insulin and tolazamide. Archives of Internal Medicine 148(8): 1745-1749, 1988

The human insulin analog insulin lispro improves insulin binding on circulating monocytes of intensively treated insulin-dependent diabetes mellitus patients. Journal of Clinical Endocrinology and Metabolism 81(6): 2319-2327, 1996

Flexible insulin therapy with glargine insulin improved glycemic control and reduced severe hypoglycemia among preschool-aged children with type 1 diabetes mellitus. Pediatrics 115(5): 1320-1324, 2005

The influence of long-term therapy with the insulin pump (CSII) in patients with type 1 diabetes mellitus on metabolic compensation and on the incidence of hypoglycaemia. Comparison with intensified conventional insulin therapy (MDI). Vnitrni Lekarstvi 53(6): 637-645, 2007

Prolonged fasting hypoglycemia due to insulin antibodies in patient with non-insulin-dependent diabetes mellitus: effect of insulin withdrawal on insulin-antibody-binding kinetics. Diabetes Care 10(2): 160-163, 1987

Comparison of prandial AIR inhaled insulin alone to intensified insulin glargine alone and to AIR insulin plus intensified insulin glargine in patients with type 2 diabetes previously treated with once-daily insulin glargine. Diabetes Technology and Therapeutics 11 Suppl 2: S63-S73, 2010

Effect of insulin plus glipizide treatment on the glycemic control insulin requirements and insulin receptor interaction in insulin dependent diabetes mellitus patients. Diabetes Research & Clinical Practice (SUPPL 1): S236-S237, 1985

Control of blood sugar in insulin-dependent diabetes: comparison of an artificial endocrine pancreas, continuous subcutaneous insulin infusion, and intensified conventional insulin therapy. New England Journal of Medicine 303(23): 1313-1318, 1980